Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice
Open Access
- 3 June 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
Abstract
Metabolic syndrome encompasses amongst other conditions like obesity and type-2 diabetes and is associated with gut microbiome (GM) dysbiosis. Fecal microbiota transplantation (FMT) has been explored to treat metabolic syndrome by restoring the GM; however, concerns on accidentally transferring pathogenic microbes remain. As a safer alternative, fecal virome transplantation (FVT, sterile-filtrated feces) has the advantage over FMT in that mainly bacteriophages are transferred. FVT from lean male donors have shown promise in alleviating the metabolic effects of high-fat diet in a preclinical mouse study. However, FVT still carries the risk of eukaryotic viral infections. To address this, recently developed methods are applied for removing or inactivating eukaryotic viruses in the viral component of FVT. Modified FVTs are compared with unmodified FVT and saline in a diet-induced obesity model on male C57BL/6 N mice. Contrasted with obese control, mice administered a modified FVT (nearly depleted for eukaryotic viruses) exhibits enhanced blood glucose clearance but not weight loss. The unmodified FVT improves liver pathology and reduces the proportions of immune cells in the adipose tissue with a non-uniform response. GM analysis suggests that bacteriophage-mediated GM modulation influences outcomes. Optimizing these approaches could lead to the development of safe bacteriophage-based therapies targeting metabolic syndrome through GM restoration.Keywords
Funding Information
- Lundbeck Foundation (R324-2019-1880)
- Novo Nordisk Fonden (NNF-20OC0063874)
This publication has 117 references indexed in Scilit:
- TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2011
- A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat DietJournal of Clinical Biochemistry and Nutrition, 2010
- CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesityNature Medicine, 2009
- A Mouse Model of Clostridium difficile–Associated DiseaseGastroenterology, 2008
- The Structure of Catalytically Active Gold on TitaniaScience, 2004
- Obesity is associated with macrophage accumulation in adipose tissueJournal of Clinical Investigation, 2003
- Removal of detergent and solvent from solvent–detergent-treated immunoglobulinsJournal of Chromatography A, 1999
- Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.1992
- Interctions of pyronin Y(G) with nucleic acidsCytometry, 1987
- CYTOSTATIC AND CYTOTOXIC PROPERTIES OF PYRONIN-Y - RELATION TO MITOCHONDRIAL LOCALIZATION OF THE DYE AND ITS INTERACTION WITH RNA1986